Enovis unit Companion Animal Health launches CT-RevitL veterinary laser therapy system in US
ENOV•ENOV•ENOV•ENOV•Enovis’ Companion Animal Health unit launched CT-RevitL, a next-generation veterinary photobiomodulation laser therapy system, in the U.S.
The system uses COMPASS dosing guidance to calibrate treatment delivery, targeting more consistent clinical outcomes across veterinary users.
The product is positioned to support recurring, non-drug treatment demand for veterinary practices as laser therapy adoption expands.
U.S. availability starts July 13, 2026; international rollout is planned in later phases.
